JPRN-UMIN000004081已完成1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreatic and biliary tract cancers - WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreatic and biliary tract cancers
Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine0 个研究点目标入组 20 人开始时间: 2010年8月21日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. There is deep-seated active infection. 2,3. There are severe complications including malignant hypertention, cardiac failure, liver cirrhosis, severe DM, severe lung fibrosis, active interstitial pneumonitis. Patients who have complications that are considered inappropriate for the trial. 4. Dependent on total parenteral nutrition (TPN) 5. There are other malignancies. 6. There are hematopoietic stem cell disorders such as myelodysplastic syndorome (MDS) and myeloproliferative disorders (MPD). 7. Pregnant or lactating woman 8. Past history of severe drug allergy 9. There is severe psychiatric disorder. 10. Responsible doctor's judged the patient inappropriate for the trial.
研究者
相似试验
已完成
1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancerpancreas cancerJPRN-UMIN000001187Department of Cancer immunotherapy, Osaka University Medical School18
已完成
1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancerpancreas cancerJPRN-UMIN000001209Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine18
已完成
1 期
PhaseI/II study of WT1 peptide vaccination plus gemcitabine and cisplatin versus gemcitabine and cisplatin in advanced biliary tract canceradvanced biliary tract cancerJPRN-UMIN000004886ational Cancer Center Hospital106
已完成
2 期
WT1 peptide-based cancer vaccine combined with gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a randomised, multicenter, phase 2 clinical studyPancreatic cancerJPRN-UMIN000005248Department of Cancer Immunotherapy, Osaka university Graduate school of Medicine150
招募中
1 期
W10TR-GBM2JPRN-jRCTs061180085eba Tetsuya90